5-ASA vs MMX nella terapia di mantenimento dell’UC
Clinical trial: Ulcerative colitis maintenance treatment with 5-ASA – a 1-year, randomized multicentre study comparing MMX with Asacol.Prantera C, Kohn…
Approfondisci...
Manitoba IBD index nuovo score di attività di malattia
The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.Clara I, Lix LM, Walker JR, Graff…
5-ASA vs MMX nella terapia di mantenimento dell’UC
Clinical trial: Ulcerative colitis maintenance treatment with 5-ASA – a 1-year, randomized multicentre study comparing MMX with Asacol.Prantera C, Kohn…
Infliximab previene colectomia
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab.Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson…
Mortalità e fattori di rischio in pazienti con pancreatite ereditaria
Mortality Rate and Risk Factors in Patients With Hereditary Pancreatitis: Uni- and Multidimensional Analyses.Rebours V, Boutron-Ruault MC, Jooste V, Bouvier…
Sicurezza long-term dell’infliximab : uno studio di coorte….
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.Fidder H, Schnitzler F, Ferrante M,…
Infezione da C.difficile piu’ frequente nelle IBD
The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients…
Incremento del rischio di infezioni nei pazienti in terapia con infliximab
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.Schneeweiss S, Korzenik…
“Nuovi cancri” nella malattia di Crohn
Cancer risks in Crohn disease patients. Hemminki K, Li X, Sundquist J, Sundquist K. Ann Oncol. 2009 Mar;20(3):574-80. BACKGROUND:…
Meta-analisi sull’efficacia di AZA e MP nella UC
Meta-analysis: efficacy of azathioprine and mercaptopurine in ulcerative colitis.Gisbert JP, Linares PM, McNicholl AG, Maté J, Gomollón F. Aliment Pharmacol…
Review sistematica sulla budesonide nel Crohn
Budesonide for maintenance of remission in Crohn’s disease.Benchimol EI, Seow CH, Otley AR, Steinhart AH. Cochrane Database Syst Rev. 2009…
M.di Crohn: l’infliximab previene la recidiva post-chirurgica
Infliximab prevents Crohn’s disease recurrence after ileal resection.Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison…
Polimorfismi genetici predicono severità del Crohn
Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort. Weersma RK, Stokkers PC, van Bodegraven…
Meta-analisi sull’efficacia del certolizumab
Systematic review: the efficacy and safety of certolizumab pegol in Crohn’s disease.Shao LM, Chen MY, Chen QY, Cai JT. Aliment…
Rischio di CRC nei pazienti IBD : uno studio di coorte….
Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Sverre Söderlund, Lena Brandt, Annika…
Mesalazina in granuli è possible la monosomministrazione?
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.Kruis W, Kiudelis…
Review sistematica : 5-ASA+immunomodulatori migliorano l’outocome delle IBD?
Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?Andrews JM, Travis SP, Gibson PR,…
Ruolo della PET nelle IBD
Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease.Halpenny DF, Burke JP, Lawlor GO,…
Aumentato rischio di neoplasie nei pazienti in terapia con Anti-TNF
The safety profile of anti-TNF therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.Lees CW, Ali…
Le gastroenteriti predispongono allo sviluppo di IBD
Infectious gastroenteritis and risk of developing inflammatory bowel disease.Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Gastroenterology. 2008…
Prevalenza e mortalità per tromboembolismo nelle IBD
Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients.Nguyen GC, Sam J. Am…
Leucocitaferesi nel tratatmento dell’UC
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Sands BE, Sandborn WJ, Feagan B, Löfberg R,…
Trials sui farmaci biologici nelle IBD: necessario caratterizzare meglio i controlli!!!!
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn’s disease. Tinè F,…
Claritromicina vs placebo nel trattamento del Crohn
Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease.Leiper K, Martin K, Ellis A, Watson AJ, Morris…
